TRC003 / C Ray Therapeutics - LARVOL DELTA

225Ac-PSMA-targeted alpha therapy (TRC003) in metastatic TNBC: A prospective, multicenter, single-arm safety/efficacy trial. (ESMO 2026) - No abstract available

Clinical • Metastases • Oncology • Triple Negative Breast Cancer

Evaluation of the safety and efficacy of TRC003 in metastatic triple-negative breast cancer: A prospective, open-label, multicenter, single-arm exploratory clinical trial. (ASCO 2026) - "Tumor assessments (contrast-enhanced CT/MRI and bone scan) will be performed every 8 weeks until disease progression is confirmed per RECIST 1.1. Clinical trial information: MR-37-25-039070."

Clinical • Metastases • Breast Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor • Triple Negative Breast Cancer • FOLH1

Evaluation of the safety, efficacy and dosimetry of TRC003 in metastatic castration-resistant prostate cancer: A prospective, open-label, single-arm study. (ASCO 2026) - P=N/A | "TRC003 was safe and well-tolerated, and exhibited efficacy for mCRPC patients who were resistant to ARPI or chemotherapy. Overall TRC003 is a promising radiopharmaceutical agent for the treatment of mCRPC. Clinical trial information: ChiCTR2400083275."

Clinical • Metastases • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor • Thrombocytopenia • Xerostomia

A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC (clinicaltrials.gov) - P1/2 | N=90 | Recruiting | Sponsor: C Ray Therapeutics | Not yet recruiting ➔ Recruiting

Enrollment open • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor

A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC (clinicaltrials.gov) - P1/2 | N=90 | Not yet recruiting | Sponsor: C Ray Therapeutics

New P1/2 trial • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor